309 related articles for article (PubMed ID: 162517)
21. Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia.
Ilondo MM; Vanderschueren-Lodeweyckx M; Pizarro M; Vlietinck R; Malvaux P; Eggermont E; Eeckels R
Horm Res; 1983; 18(4):175-85. PubMed ID: 6227545
[TBL] [Abstract][Full Text] [Related]
22. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
23. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.
Parker CR; Slayden SM; Azziz R; Crabbe SL; Hines GA; Boots LR; Bae S
J Clin Endocrinol Metab; 2000 Jan; 85(1):48-54. PubMed ID: 10634362
[TBL] [Abstract][Full Text] [Related]
24. Peripheral steroid levels in a patient with virilizing adrenal adenoma.
Chakmakjian ZH; Abraham GE
Obstet Gynecol; 1975 Nov; 46(5):544-8. PubMed ID: 127956
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
Bélanger A; Dupont A; Labrie F
J Clin Endocrinol Metab; 1984 Sep; 59(3):422-6. PubMed ID: 6086697
[TBL] [Abstract][Full Text] [Related]
26. The hormonal activity of the postmenopausal ovary.
Vermeulen A
J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
[TBL] [Abstract][Full Text] [Related]
27. Effects of estrogens on adrenal 3 beta-hydroxysteroid dehydrogenase in ovariectomized women.
Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Sep; 43(3):561-70. PubMed ID: 182711
[TBL] [Abstract][Full Text] [Related]
28. The modulating role of obesity and 17 beta-estradiol (E2) on bound and unbound E2 and adrenal androgens in oophorectomized women.
Lobo RA; March CM; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1982 Feb; 54(2):320-4. PubMed ID: 6459339
[TBL] [Abstract][Full Text] [Related]
29. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
[TBL] [Abstract][Full Text] [Related]
30. Adrenal hyperresponsiveness to ACTH stimulation in women with polycystic ovary syndrome: an adrenarchal type of response.
Anapliotou MG; Syrigos K; Papanicolaou T; Panayiotakopoulos G; Kalos A; Batrinos ML
Int J Fertil; 1990; 35(4):230-9. PubMed ID: 1977716
[TBL] [Abstract][Full Text] [Related]
31. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
32. Seventy-two hour infusions of LHRH in normal men: gonadotropin and testicular steroid responses.
McNeil LW; McKenna TJ; Lacroix A; Benveniste R; Rabin D
J Clin Endocrinol Metab; 1979 Jul; 49(1):149-51. PubMed ID: 156193
[TBL] [Abstract][Full Text] [Related]
33. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
[TBL] [Abstract][Full Text] [Related]
34. Serum adrenal steroid concentrations in premature infants.
Lee MM; Rajagopalan L; Berg GJ; Moshang T
J Clin Endocrinol Metab; 1989 Dec; 69(6):1133-6. PubMed ID: 2531155
[TBL] [Abstract][Full Text] [Related]
35. Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness.
Spratt DI; Longcope C; Cox PM; Bigos ST; Wilbur-Welling C
J Clin Endocrinol Metab; 1993 Jun; 76(6):1542-7. PubMed ID: 8501162
[TBL] [Abstract][Full Text] [Related]
36. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin R; Labrie F
Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
[TBL] [Abstract][Full Text] [Related]
38. Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Young J; Couzinet B; Pholsena M; Nahoul K; Labrie F; Schaison G
J Clin Endocrinol Metab; 1994 Feb; 78(2):299-304. PubMed ID: 8106615
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
Dowsett M; Harris AL; Stuart-Harris R; Hill M; Cantwell BM; Smith IE; Jeffcoate SL
Br J Cancer; 1985 Oct; 52(4):525-9. PubMed ID: 2933050
[TBL] [Abstract][Full Text] [Related]
40. Aminoglutethimide dose and hormone suppression in advanced breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; Smith IE
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):493-8. PubMed ID: 6222901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
